Boyd Watterson Asset Management’s CRISPR Therapeutics CRSP Stock Holding History

Boyd Watterson Asset Management’s Portfolio CRSP Stock Details CRSP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell
2021 Q3	$632K	Buy
2021 Q2	$754K	Buy